Haemodialysis and Peritoneal Dialysis Market Report and Forecast 2025-2034

The global haemodialysis and peritoneal dialysis market was valued at USD 84.50 Billion in 2024, driven by the rising occurrence of diabetes, and the growing prevalence of hypertension across the globe. The market is anticipated to grow at a CAGR of 5.80% during the forecast period of 2025-2034, with the values likely to reach USD 148.50 Billion by 2034.

Haemodialysis and Peritoneal Dialysis Market Overview

Haemodialysis and peritoneal dialysis are treatments for kidney failure that filter waste, toxins, and excess fluids from the blood. In haemodialysis, blood is drawn from the body, passed through a dialysis machine with a synthetic filter (dialyser), and returned to the body. This procedure is usually performed in a clinic several times a week. In peritoneal dialysis, the peritoneum (lining of the abdomen) acts as a natural filter. A dialysis solution is introduced into the abdominal cavity via a catheter, absorbing waste and fluids, and is then drained. It can be performed at home and offers more flexibility.

Haemodialysis and Peritoneal Dialysis Market Growth Drivers

Innovative Product Launches to Boost Market Growth

The global market is being driven by a growing prevalence of chronic kidney disease (CKD) and a rising demand for advanced dialysis treatments that improve patient outcomes. Additionally, the push towards minimally invasive therapies and better patient care is fostering innovation in dialysis technology. For instance, in October 2024, Fresenius Medical Care, a leading provider in renal care, announced that it would introduce hemodiafiltration (HDF) therapy into its U.S. clinics starting in 2025. HDF combines convection and diffusion to enhance the removal of larger solutes, offering improved efficacy in dialysis treatment. With FDA clearance for the 5008X Hemodialysis System, Fresenius Medical Care’s entry of this advanced therapy is poised to positively impact the market by offering a more effective and personalised treatment option, potentially increasing the adoption of HDF systems across the U.S. market and driving significant growth.

Technical Advancements in Devices to Meet Rising Haemodialysis and Peritoneal Dialysis Market Demand

As peritoneal dialysis (PD) becomes an essential option for many patients, advancements such as the development of new dialysis bags are critical. For instance, In March 2024, Mitra Industries launched a triple-chambered peritoneal dialysis bag designed with near-neutral pH and low glucose degradation products (GDPs), aimed at improving the quality of care for chronic kidney disease patients. This new product promises superior outcomes for PD patients, enhancing patient comfort and safety. With kidney transplant shortages increasing, innovations like this PD bag are set to drive market growth by providing better, more efficient options for those reliant on dialysis therapy, contributing to the ongoing evolution of the dialysis sector.

Haemodialysis and Peritoneal Dialysis Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Innovative Technologies Accelerating Growth in Dialysis Treatment Market

The global haemodialysis and peritoneal dialysis market is witnessing significant growth due to advancements in dialysis technologies, such as wearable and portable devices. These innovations aim to improve patient mobility and comfort, addressing the limitations of traditional dialysis methods. Additionally, the integration of IoT and AI in dialysis machines is enhancing treatment precision and patient monitoring. Rising prevalence of end-stage renal disease (ESRD) and growing awareness about home dialysis solutions further fuel market expansion. Governments and healthcare organisations worldwide are increasingly supporting dialysis innovations, providing a favourable environment for market growth in developed and emerging economies alike.

Collaborations and Initiatives Driving Haemodialysis and Peritoneal Dialysis Market Development

Strategic collaborations between healthcare providers, research institutes, and dialysis device manufacturers are accelerating market development. Key players are focusing on partnerships to enhance product offerings and expand geographic reach. Initiatives to improve dialysis care in underdeveloped regions, coupled with public-private partnerships, are also playing a vital role. Increasing investments in R&D for advanced dialysis products and techniques further contribute to market development. Additionally, the rising preference for home-based dialysis treatment solutions underscores a shift toward patient-centric care, propelling the market's growth trajectory and ensuring sustainable development in the long term.

Rising Dialysis Treatment Demand Boosts Market Value Worldwide

The global haemodialysis and peritoneal dialysis market value is significantly growing, driven by the increasing global prevalence of kidney diseases and diabetes. Rising awareness about early diagnosis and treatment options has significantly contributed to higher adoption rates. Moreover, favourable reimbursement policies in developed regions and growing affordability in emerging economies are boosting market penetration. Technological advancements that reduce treatment times and improve patient outcomes further enhance the market's attractiveness. Manufacturers' focus on developing cost-effective dialysis systems for low-resource settings also supports market expansion, ensuring treatment accessibility and boosting overall market value.

Expanding Dialysis Solutions Addressing Evolving Patient and Market Needs to Boost Haemodialysis and Peritoneal Dialysis Market Growth

Patient preferences and evolving market needs are shaping the haemodialysis and peritoneal dialysis market. There is a notable shift toward home-based dialysis treatments, driven by convenience and reduced hospital visits. Customised treatment plans and wearable dialysis devices are gaining traction as they align with patient-centric healthcare models. Furthermore, the growing geriatric population and the increasing prevalence of lifestyle-related kidney disorders are influencing product innovation. Manufacturers are also prioritising eco-friendly dialysis solutions to reduce environmental impact, meeting sustainability goals while catering to healthcare demands, thus opening new avenues for market players globally.

Haemodialysis and Peritoneal Dialysis Market Segmentation

"Haemodialysis and Peritoneal Dialysis Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

• Haemodialysis
• Conventional Haemodialysis
• Nocturnal Haemodialysis
• Short Daily Haemodialysis
• Peritoneal Dialysis
• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

Market Breakup by Product and Services

• Device
• Machine Center-Use Dialysis Machines Home Use Dialysis Machines
• Dialyzer By Material Synthetic Dialyzer Cellulose Based Dialyzer By Flux High Flux Dialyzer Low Flux Dialyzer
• Water Treatment System Central Water Disinfection System Portable Water Disinfection System
• Others
• Consumables
• Bloodline
• Concentrates
• Alkaline Concentrates
• Acidic Concentrates
• Catheters
• Others
• Services
• In-Center Services
• Home Services

Market Breakup by Indication

• End Stage Renal Disease
• Acute Kidney Injury
• Others

Market Breakup by End User

• Hospitals
• Independent Dialysis Centers
• Home Care Settings
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Haemodialysis and Peritoneal Dialysis Market Share

Market Share by Type to Witness Significant Growth

The haemodialysis segment holds the largest market share within the dialysis sector due to the widespread adoption of this treatment for end-stage renal disease (ESRD). Conventional haemodialysis is the most common method, driving demand in hospitals and dialysis centres worldwide. Factors such as the growing prevalence of kidney disease, improved dialysis technologies, and increased accessibility contribute to the segment’s dominance. Nocturnal and short daily haemodialysis options are gaining popularity due to their improved comfort and outcomes. As patient-centric approaches gain traction, this segment is poised for significant growth, particularly in emerging markets where ESRD rates are rising.

Dialysis Devices to Lead the Haemodialysis and Peritoneal Dialysis Market Segmentation by Product and Services

Dialysis devices, particularly haemodialysis machines, are estimated to dominate the product and services segment, accounting for the largest market share. Advancements in machine design, including home-use machines and more efficient centre-use systems, drive market demand. Additionally, the growing preference for at-home dialysis solutions contributes significantly to market growth. Dialysers, especially high-flux types, are seeing increased adoption due to their efficiency in filtering toxins, further boosting the segment’s value. The ongoing trend towards home care and technological advancements in water treatment systems are expected to maintain this dominance in the forecast period, with both developed and emerging regions embracing these innovations.

End-Stage Renal Disease Leading the Haemodialysis and Peritoneal Dialysis Market by Indication

End-stage renal disease (ESRD) will likely emerge as a noticeable indication for dialysis treatment, holding the largest market share. The global rise in diabetes, hypertension, and other kidney-related ailments has significantly increased the incidence of ESRD, directly impacting market demand. As a result, both haemodialysis and peritoneal dialysis treatments are extensively used to manage this condition. The need for chronic care, coupled with advancements in dialysis technology that improve patient outcomes, ensures continuous growth in this segment. In the forecast period, the growing focus on patient quality of life and innovative home dialysis options will further strengthen this segment’s market dominance.

Haemodialysis and Peritoneal Dialysis Market Share by End User to Witness Significant Growth

Independent dialysis centres hold the largest market share among dialysis end users, driven by their dedicated focus on providing specialised dialysis services. These centres offer a higher level of personalised care compared to hospitals, particularly in regions with high ESRD rates. The increasing number of standalone dialysis facilities, coupled with their cost-effectiveness and ability to cater to patient preferences for scheduled treatments, supports their dominance. Additionally, the rising preference for outpatient services and home dialysis options is enhancing the growth prospects for these centres. As the global dialysis burden increases, independent dialysis centres are well-positioned for continued market expansion.

Haemodialysis and Peritoneal Dialysis Market Analysis by Region

North America holds the largest market share primarily driven by factors like a high prevalence of kidney diseases, particularly end-stage renal disease (ESRD), and benefits from robust healthcare infrastructure. The increasing adoption of home dialysis solutions, supported by favourable reimbursement policies, drives market growth. Additionally, technological advancements in dialysis equipment, including portable machines and wearable devices, are more rapidly embraced in North America due to strong regulatory frameworks and innovation incentives. The established presence of leading market players and a well-developed healthcare system further contribute to North America's dominance. Furthermore, the region is seeing rising investments in R&D for more effective and patient-friendly dialysis treatments.

Leading Players in the Haemodialysis and Peritoneal Dialysis Market

The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Fresenius SE & Co. KGaA

Headquartered in Bad Homburg, Germany, Fresenius was established in 1912. A global healthcare group, it specialises in dialysis, hospital care, and medical devices. Its portfolio includes dialysis machines, dialysers, and services through its subsidiary Fresenius Medical Care, the world's leading provider of dialysis products. Fresenius also offers a broad range of pharmaceutical products, including intravenous solutions, and hospital equipment. With a strong presence in over 100 countries, it remains a key player in the healthcare industry, particularly in renal care and critical care solutions.

B. Braun SE

Founded in 1839 and headquartered in Melsungen, Germany, B. Braun SE is a leading global manufacturer of medical and pharmaceutical products. Its portfolio spans across areas such as dialysis, anaesthesia, surgery, and infection control. B. Braun's dialysis offerings include machines, dialysers, and consumables for both haemodialysis and peritoneal dialysis. The company is also known for its comprehensive line of infusion pumps, catheters, and surgical instruments, serving healthcare providers worldwide. B. Braun is committed to improving patient safety and healthcare quality through innovative products and solutions.

Baxter International

Established in 1931 and headquartered in Deerfield, Illinois, USA, Baxter International is a prominent global healthcare company. It provides essential healthcare products, including renal care solutions such as dialysis equipment, fluids, and consumables. Baxter’s portfolio also covers areas like anaesthesia, critical care, and nutritional therapies. The company's renal division offers innovative haemodialysis and peritoneal dialysis products, including machines, dialysers, and solutions for home and in-centre care. Baxter's global presence ensures it plays a key role in transforming healthcare with innovative, life-sustaining therapies.

BD (Becton, Dickinson and Company)

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD is a global leader in medical technology. Its portfolio encompasses products for medication management, diagnostics, biosciences, and dialysis care. BD provides dialysis-related consumables, including needles, catheters, and blood collection systems. The company’s focus on innovation and patient safety positions it as a key player in improving healthcare outcomes. BD is also known for its contributions to infectious disease diagnostics and vaccine delivery, supporting healthcare systems worldwide with a broad range of medical products.

Other key players in the market include Nikkiso Co., Ltd, Nipro, Asahi Kasei Co., Ltd, Allmed Medical Care Holdings Limited, U.S. Renal Care, Inc., American Dialysis Centers, and NephroPlus.

Key Questions Answered in the Haemodialysis and Peritoneal Dialysis Market

• What was the global haemodialysis and peritoneal dialysis market value in 2024?
• What is the global haemodialysis and peritoneal dialysis market forecast outlook for 2025-2034?
• What is market segmentation based on type?
• How is the market segmented based on product and service?
• How is the market segmented based on indications?
• How is the market segmented based on end users?
• What are the major factors aiding the global haemodialysis and peritoneal dialysis market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major global haemodialysis and peritoneal dialysis market trends?
• Which type will lead the market segment?
• Which product and service will lead the market segment?
• Which indications will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the global haemodialysis and peritoneal dialysis market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.